The evaluation of the Myxovirus Resistance 1 protein in serum and saliva to monitor disease activation in primary Sjögren’s syndrome. Clinics, [S. l.], v. 74, p. e631, 2019. DOI: 10.6061/clinics/2019/e631. Disponível em: https://www.revistas.usp.br/clinics/article/view/159385.. Acesso em: 8 may. 2024.